Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World
Cellular therapy has used mesenchymal stem cells (MSCs), which in cell culture are multipotent progenitors capable of producing a variety of cells limited to the mesoderm layer. There are two types of MSC sources: (1) adult MSCs, which are obtained from bone marrow, adipose tissue, peripheral blood,...
Saved in:
Main Authors: | Luis E. Fernández-Garza (Author), Silvia A. Barrera-Barrera (Author), Hugo A. Barrera-Saldaña (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In memoriam de tres gigantes de la comunidad médica de Monterrey
by: Hugo A. Barrera-Saldaña
Published: (2022) -
Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States
by: Robert Roskoski Jr
Published: (2023) -
Organizational structure and funding of health technology assessment agencies around the world
by: G. R. Khachatryan, et al.
Published: (2019) -
Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States
by: Mijin Lee, et al.
Published: (2023) -
Regulatory Effect of Mesenchymal Stem Cells on T Cell Phenotypes in Autoimmune Diseases
by: Zhiping Wei, et al.
Published: (2021)